These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10704636)

  • 1. A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy.
    Jackson TL; Byrne HM
    Math Biosci; 2000 Mar; 164(1):17-38. PubMed ID: 10704636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular tumor growth and treatment: consequences of polyclonality, competition and dynamic vascular support.
    Jackson TL
    J Math Biol; 2002 Mar; 44(3):201-26. PubMed ID: 12148489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mathematical model of drug resistance: heterogeneous tumors.
    Panetta JC
    Math Biosci; 1998 Jan; 147(1):41-61. PubMed ID: 9401351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiscale modelling of fluid and drug transport in vascular tumours.
    Shipley RJ; Chapman SJ
    Bull Math Biol; 2010 Aug; 72(6):1464-91. PubMed ID: 20099043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical modelling of drug transport in tumour multicell spheroids and monolayer cultures.
    Ward JP; King JR
    Math Biosci; 2003 Feb; 181(2):177-207. PubMed ID: 12445761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What does not kill a tumour may make it stronger: In silico insights into chemotherapeutic drug resistance.
    Hamis S; Nithiarasu P; Powathil GG
    J Theor Biol; 2018 Oct; 454():253-267. PubMed ID: 29909142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A delay differential equation model for tumor growth.
    Villasana M; Radunskaya A
    J Math Biol; 2003 Sep; 47(3):270-94. PubMed ID: 12955460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
    Fuchs J; Wenderoth M; von Schweinitz D; Haindl J; Leuschner I
    Cancer; 1998 Dec; 83(11):2400-7. PubMed ID: 9840541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model.
    Chen JH; Kuo YH; Luh HP
    Math Biosci; 2013 Oct; 245(2):282-98. PubMed ID: 23927854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling drug resistance in a conjoint normal-tumor setting.
    Feizabadi MS; Witten TM
    Theor Biol Med Model; 2015 Jan; 12():3. PubMed ID: 25588472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the chemotherapy-induced selection of drug-resistant traits during tumor growth.
    Cho H; Levy D
    J Theor Biol; 2018 Jan; 436():120-134. PubMed ID: 29030212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):211-28. PubMed ID: 7881195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression and regrowth of tumour cords following single-dose anticancer treatment.
    Bertuzzi A; D'Onofrio A; Fasano A; Gandolfi A
    Bull Math Biol; 2003 Sep; 65(5):903-31. PubMed ID: 12909255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model for metastases formation.
    Markovitch S
    Int J Biomed Comput; 1993 Jan; 32(1):19-33. PubMed ID: 8425750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach.
    Albini A; Marchisone C; Del Grosso F; Benelli R; Masiello L; Tacchetti C; Bono M; Ferrantini M; Rozera C; Truini M; Belardelli F; Santi L; Noonan DM
    Am J Pathol; 2000 Apr; 156(4):1381-93. PubMed ID: 10751362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the influence of mechanical stress on anticancer treatments through a multiphase porous media model.
    Mascheroni P; Boso D; Preziosi L; Schrefler BA
    J Theor Biol; 2017 May; 421():179-188. PubMed ID: 28392183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delay equations modeling the effects of phase-specific drugs and immunotherapy on proliferating tumor cells.
    Barbarossa MV; Kuttler C; Zinsl J
    Math Biosci Eng; 2012 Apr; 9(2):241-57. PubMed ID: 22901063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bilinear control model for tumor growth and chemotherapy.
    Vaidya VG; Alexandro FJ; Vaidya PG
    Int J Biomed Comput; 1985 Sep; 17(2):145-54. PubMed ID: 4055120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous injection of an immunoconjugate (anti-PSA-IgG conjugated to 5-fluoro-2'-deoxyuridine) selectively inhibits cell proliferation and induces cell death in human prostate cancer cell tumors grown in nude mice.
    Sinha AA; Quast BJ; Reddy PK; Elson MK; Wilson MJ
    Anticancer Res; 1999; 19(2A):893-902. PubMed ID: 10368631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methionine depletion enhances the antitumoral efficacy of cytotoxic agents in drug-resistant human tumor xenografts.
    Poirson-Bichat F; Gonçalves RA; Miccoli L; Dutrillaux B; Poupon MF
    Clin Cancer Res; 2000 Feb; 6(2):643-53. PubMed ID: 10690550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.